T1	PROC 46 98	Ensayo clínico doble ciego, aleatorizado, controlado
T2	PROC 105 124	evaluar la eficacia
#1	AnnotatorNotes T2	C1707887; Efficacy Study; Research Activity
T3	ANAT 132 164	células mesenquimales estromales
#2	AnnotatorNotes T3	C3178844; Mesenchymal Stromal Cells; Cell
T4	DISO 241 249	COVID-19
#3	AnnotatorNotes T4	C5203670; COVID19 (disease); Disease or Syndrome
T5	DISO 193 231	síndrome de distrés respiratorio agudo
#4	AnnotatorNotes T5	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome | C0748355; Acute respiratory distress; Disease or Syndrome
T6	DISO 273 311	Síndrome de distrés respiratorio agudo
#5	AnnotatorNotes T6	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome | C0748355; Acute respiratory distress; Disease or Syndrome
T7	PROC 351 375	Consentimiento informado
#6	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	PROC 441 460	consentimiento oral
#7	AnnotatorNotes T8	C1608381; Consent Mode - Verbal; Health Care Activity
T9	DISO 668 692	Infección por SARS-CoV-2
#8	AnnotatorNotes T9	C5203670; COVID19 (disease); Disease or Syndrome
T10	PROC 510 536	consentimiento por escrito
#9	AnnotatorNotes T10	C0811746; Obtain written consent; Health Care Activity
T11	PROC 761 768	muestra
T12	PROC 855 866	PaO2 / FiO2
#10	AnnotatorNotes T12	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T13	ANAT 716 743	muestra naso u orofaríngeos
T14	DISO 811 821	enfermedad
#11	AnnotatorNotes T14	C0012634; Disease; Disease or Syndrome
T15	DISO 826 830	SDRA
#12	AnnotatorNotes T15	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome | C0748355; Acute respiratory distress; Disease or Syndrome
T16	PROC 942 956	aleatorización
#13	AnnotatorNotes T16	C0034656; Randomization; Research Activity
T17	PROC 989 1009	ventilación invasiva
T18	PROC 1064 1074	intubación
#14	AnnotatorNotes T18	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T19	PROC 1292 1304	tratamientos
#15	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	PROC 1354 1365	reanimación
#16	AnnotatorNotes T20	C0007203; Cardiopulmonary Resuscitation; Therapeutic or Preventive Procedure
T21	DISO 1381 1391	enfermedad
#17	AnnotatorNotes T21	C0012634; Disease; Disease or Syndrome
T22	DISO 1394 1404	alteración
T23	PROC 1515 1526	tratamiento
#18	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	DISO 1550 1568	trastorno pulmonar
#19	AnnotatorNotes T24	C0024115; Lung diseases; Disease or Syndrome
T25	PROC 1599 1626	oxigenoterapia domiciliaria
#20	AnnotatorNotes T25	C1960973; Home oxygen therapy; Therapeutic or Preventive Procedure
T26	PROC 1659 1671	hemodiálisis
#21	AnnotatorNotes T26	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T27	PROC 1674 1688	hemofiltración
#22	AnnotatorNotes T27	C0019014; Hemofiltration; Therapeutic or Preventive Procedure
T28	PROC 1706 1736	administración del tratamiento
T29	PROC 1741 1752	Diagnóstico
#23	AnnotatorNotes T29	C0011900; Diagnosis; Diagnostic Procedure
T30	DISO 1763 1779	embolia pulmonar
#24	AnnotatorNotes T30	C0034065; Pulmonary Embolism; Pathologic Function
T31	DISO 1784 1793	Neoplasia
#25	AnnotatorNotes T31	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T32	DISO 1810 1827	carcinoma in situ
#26	AnnotatorNotes T32	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T33	DISO 1830 1839	basalioma
#27	AnnotatorNotes T33	C0007117; Basal cell carcinoma; Neoplastic Process
T34	DISO 1844 1851	Alergia
#28	AnnotatorNotes T34	C0020517; Hypersensitivity; Pathologic Function
T35	PROC 2012 2030	prueba de embarazo
#29	AnnotatorNotes T35	C0032976; Pregnancy Tests; Diagnostic Procedure
T36	DISO 2155 2163	COVID-19
#30	AnnotatorNotes T36	C5203670; COVID19 (disease); Disease or Syndrome
T37	PROC 2103 2117	ensayo clínico
#31	AnnotatorNotes T37	C0008976; Clinical Trials; Research Activity
T38	PROC 2125 2149	tratamiento experimental
#32	AnnotatorNotes T38	C2585119; Experimental therapeutic procedure; Therapeutic or Preventive Procedure
T39	CHEM 2185 2196	medicamento
#33	AnnotatorNotes T39	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T40	DISO 1351 1365	No reanimación
#34	AnnotatorNotes T40	C0582114; DNR - Do not resuscitate status; Finding
T41	PROC 2243 2268	protocolos de tratamiento
#35	AnnotatorNotes T41	C0040808; Treatment Protocols; Therapeutic or Preventive Procedure
T43	PROC 2431 2445	ensayo clínico
#36	AnnotatorNotes T43	C0008976; Clinical Trials; Research Activity
T44	DISO 316 321	COVID
T45	PROC 398 412	procedimientos
#37	AnnotatorNotes T45	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T46	PROC 708 711	PCR
#38	AnnotatorNotes T46	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T47	PROC 1097 1112	admisión en UCI
T48	DISO 1212 1218	muerte
#39	AnnotatorNotes T48	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T49	ANAT 1921 1924	CME
#40	AnnotatorNotes T49	C3178844; Mesenchymal Stromal Cells; Cell
T50	ANAT 1560 1568	pulmonar
#41	AnnotatorNotes T50	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T51	PROC 1653 1657	ECMO
#42	AnnotatorNotes T51	C0015357; Extracorporeal Membrane Oxygenation; Therapeutic or Preventive Procedure
T52	ANAT 1771 1779	pulmonar
#43	AnnotatorNotes T52	C0034052; Pulmonary artery structure; Body Part, Organ, or Organ Component | C1269026; Entire pulmonary artery; Body Part, Organ, or Organ Component
T53	Date 13 17	2020
T54	LIVB 179 188	pacientes
#44	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T57	LIVB 541 549	paciente
#45	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 556 570	representantes
#46	AnnotatorNotes T58	C0030701; Patient Representatives; Professional or Occupational Group | C0600419; Patient Agent; Group | C1998038; Patient advocate (person); Population Group (?)
T60	LIVB 599 616	Pacientes adultos
#47	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T62	Age 617 625	≥18 años
T63	Duration 904 921	al menos 72 horas
T64	LIVB 965 974	pacientes
#48	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Duration 1034 1046	las 48 horas
T66	LIVB 1123 1142	equipo investigador
#49	AnnotatorNotes T66	C0035173; Research Personnel; Professional or Occupational Group
T67	Duration 1229 1252	las siguientes 24 horas
T68	Neg_cue 1351 1353	No
T69	LIVB 1443 1455	investigador
#50	AnnotatorNotes T69	C0035173; Research Personnel; Professional or Occupational Group
T70	LIVB 1469 1477	paciente
#51	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T72	LIVB 1631 1639	Paciente
#52	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	Date 1753 1759	actual
T74	Neg_cue 1802 1809	excepto
T75	PHYS 1940 1948	Embarazo
#53	AnnotatorNotes T75	C0032961; Pregnancy; Organism Function
T76	PHYS 1951 1960	lactancia
#54	AnnotatorNotes T76	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T77	Date 1961 1967	actual
T78	LIVB 1973 1995	mujeres en edad fértil
#55	AnnotatorNotes T78	C4324275; Woman of childbearing potential; Population Group
T79	Age 1984 1995	edad fértil
T81	Neg_cue 2031 2039	negativa
T82	Date 2090 2096	actual
T85	LIVB 2358 2370	investigador
#56	AnnotatorNotes T85	C0035173; Research Personnel; Professional or Occupational Group
T86	LIVB 2400 2408	paciente
#57	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	PHYS 213 225	respiratorio
#58	AnnotatorNotes T87	C0035203; Respiration; Physiologic Function
T88	PHYS 293 305	respiratorio
#59	AnnotatorNotes T88	C0035203; Respiration; Physiologic Function
T89	PHYS 2022 2030	embarazo
#60	AnnotatorNotes T89	C0032961; Pregnancy; Organism Function
T55	LIVB 682 692	SARS-CoV-2
#61	AnnotatorNotes T55	C5203676; SARS-CoV-2; Virus
A1	Population_data T60 Age
A2	Assertion T20 Negated
A3	Status T24 History_of
A4	Assertion T32 Negated
A5	Assertion T33 Negated
A6	Assertion T89 Negated
A7	Status T34 History_of
#62	AnnotatorNotes T44	C5203670; COVID19 (disease); Disease or Syndrome
#63	AnnotatorNotes T1	C0013072; Double-Blind Method; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
#64	AnnotatorNotes T13	C3536619; Nasopharyngeal and oropharyngeal swab; Body Substance 
#65	AnnotatorNotes T11	C0200345; Specimen Collection; Health Care Activity 
#66	AnnotatorNotes T47	C5419131; Intensive Care Unit Stay; Health Care Activity
#67	AnnotatorNotes T73	C0521116; Current (present time); Temporal Concept 
#68	AnnotatorNotes T77	C0521116; Current (present time); Temporal Concept 
#69	AnnotatorNotes T82	C0521116; Current (present time); Temporal Concept 
T56	Observation 1488 1506	candidato adecuado
A8	Assertion T56 Negated
T59	Quantifier_or_Qualifier 2200 2208	indicado
A9	Assertion T59 Negated
#70	AnnotatorNotes T59	C3146298; Indication; Idea or Concept
T61	Neg_cue 2197 2199	no
T71	CONC 2286 2307	criterio de exclusión
A10	Assertion T71 Negated
#71	AnnotatorNotes T71	C0680251; Exclusion Criteria; Functional Concept
T80	Neg_cue 2277 2279	no
T83	Neg_cue 1478 1480	no
R1	Negation Arg1:T68 Arg2:T20	
R2	Negation Arg1:T83 Arg2:T56	
R3	Negation Arg1:T74 Arg2:T32	
R4	Negation Arg1:T74 Arg2:T33	
R5	Negation Arg1:T81 Arg2:T89	
R6	Negation Arg1:T61 Arg2:T59	
R7	Negation Arg1:T80 Arg2:T71	
T84	Quantifier_or_Qualifier 165 175	alogénicas
#72	AnnotatorNotes T84	C1515895; Allogeneic; Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T84	
R9	Experiences Arg1:T54 Arg2:T5	
R10	Experiences Arg1:T54 Arg2:T87	
R11	Experiences Arg1:T54 Arg2:T4	
R12	Causes Arg1:T4 Arg2:T5	
R14	Causes Arg1:T44 Arg2:T6	
R15	Before Arg1:T7 Arg2:T45	
R16	Before Arg1:T8 Arg2:T45	
R17	Has_Age Arg1:T60 Arg2:T62	
T90	CONC 654 663	inclusión
#73	AnnotatorNotes T90	C1512693; Inclusion; Qualitative Concept
R18	Overlap Arg1:T90 Arg2:T62	
R19	Causes Arg1:T55 Arg2:T9	
R21	Location_of Arg1:T13 Arg2:T46	
R22	Before Arg1:T11 Arg2:T46	
R23	Overlap Arg1:T11 Arg2:T14	
T91	Quantifier_or_Qualifier 831 847	moderado a grave
#74	AnnotatorNotes T91	C1299393; Moderate to severe; Qualitative Concept
R24	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T91	
T92	Result_or_Value 867 894	igual o inferior a 200 mmHg
R26	Has_Result_or_Value Arg1:T12 Arg2:T92	
R27	Has_Duration_or_Interval Arg1:T15 Arg2:T63	
R28	Overlap Arg1:T15 Arg2:T16	
R29	Experiences Arg1:T64 Arg2:T17	
#75	AnnotatorNotes T17	C1868981; Invasive mechanical ventilation; Therapeutic or Preventive Procedure (?)
T93	Observation 1014 1023	elegibles
#76	AnnotatorNotes T93	C1302261; Patient eligible for clinical trial; Finding
R30	Has_Quantifier_or_Qualifier Arg1:T64 Arg2:T93	
R31	Overlap Arg1:T93 Arg2:T65	
R32	After Arg1:T93 Arg2:T18	
R33	Before Arg1:T18 Arg2:T17	
R34	Experiences Arg1:T64 Arg2:T18	
T94	Observation 1173 1218	Progresión inminente e inevitable a la muerte
#77	AnnotatorNotes T94	C2363727; Death imminent; Finding
R35	Overlap Arg1:T94 Arg2:T67	
R36	Overlap Arg1:T48 Arg2:T67	
R37	Before Arg1:T19 Arg2:T48	
#78	AnnotatorNotes T22	C0221423; Illness (finding); Sign or Symptom
T95	Quantifier_or_Qualifier 1408 1421	fase terminal
#79	AnnotatorNotes T95	C0205088; End-stage; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T95	
R39	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T95	
R40	Experiences Arg1:T70 Arg2:T21	
R41	Experiences Arg1:T70 Arg2:T22	
R42	Before Arg1:T21 Arg2:T56	
R43	Before Arg1:T22 Arg2:T56	
R46	Experiences Arg1:T70 Arg2:T23	
R47	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T56	
R48	Location_of Arg1:T50 Arg2:T24	
T96	Quantifier_or_Qualifier 1569 1585	moderado / grave
R49	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T96	
#80	AnnotatorNotes T96	C1299393; Moderate to severe; Qualitative Concept
R50	Experiences Arg1:T72 Arg2:T51	
R51	Experiences Arg1:T72 Arg2:T26	
R52	Experiences Arg1:T72 Arg2:T27	
R53	Overlap Arg1:T51 Arg2:T28	
R54	Overlap Arg1:T26 Arg2:T28	
R55	Overlap Arg1:T27 Arg2:T28	
#81	AnnotatorNotes T28	C3469597; Administration of medication; Therapeutic or Preventive Procedure
R56	Overlap Arg1:T29 Arg2:T73	
R57	Location_of Arg1:T52 Arg2:T30	
T97	Quantifier_or_Qualifier 1794 1800	activa
R58	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T97	
#82	AnnotatorNotes T97	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
T98	Quantifier_or_Qualifier 1925 1935	alogénicas
#83	AnnotatorNotes T98	C1515895; Allogeneic; Qualitative Concept
R59	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T98	
R60	Overlap Arg1:T75 Arg2:T77	
R61	Overlap Arg1:T76 Arg2:T77	
R62	Has_Age Arg1:T78 Arg2:T79	
R63	Experiences Arg1:T78 Arg2:T35	
R64	Experiences Arg1:T78 Arg2:T89	
T99	CONC 2046 2055	inclusión
#84	AnnotatorNotes T99	C1512693; Inclusion; Qualitative Concept
R65	Overlap Arg1:T35 Arg2:T99	
R66	Overlap Arg1:T89 Arg2:T99	
R67	Overlap Arg1:T75 Arg2:T99	
R68	Overlap Arg1:T76 Arg2:T99	
T100	Observation 2076 2089;2097 2117	Participación en un ensayo clínico
R69	Overlap Arg1:T100 Arg2:T82	
R70	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T59	
T101	Observation 2372 2382;2414 2445	comprometa participar en el ensayo clínico
R71	Overlap Arg1:T46 Arg2:T14	
#87	AnnotatorNotes T56	C1302261; Patient eligible for clinical trial; Finding (?)
R13	Overlap Arg1:T9 Arg2:T46	
R20	Overlap Arg1:T9 Arg2:T11	
#85	AnnotatorNotes T100	C1278516; Patient participation status; Finding (?)
A11	Experiencer T54 Patient
A12	Experiencer T57 Patient
A13	Experiencer T58 Other
A14	Status T10 Future
A15	Experiencer T60 Patient
A16	Experiencer T64 Patient
A17	Experiencer T66 Other
A18	Status T47 Future
A19	Experiencer T69 Other
A20	Experiencer T70 Patient
A21	Experiencer T72 Patient
A22	Experiencer T78 Patient
A23	Experiencer T85 Other
A24	Experiencer T86 Patient
A25	Status T48 Future
T42	Result_or_Value 2031 2039	negativa
R25	Has_Result_or_Value Arg1:T35 Arg2:T42	
